美沙拉嗪联合康复新液治疗溃疡性结肠炎的疗效观察OA
Effect Observation of Treatment for Mesalazine Joint Kangfuxin Solution Curative Ulcerative Colitis
目的观察美沙拉嗪联合康复新液治疗溃疡性结肠炎(UC)的临床疗效及安全性。方法选择我院收治的溃疡性结肠炎患者110例，将所有患者随机分为两组，每组55例。对照组给予口服美沙拉嗪治疗，治疗组在对照组治疗的基础上加用康复新液保留灌肠，治疗后比较两组临床疗效。结果治疗组总有效率为94.5%，对照组总有效率为80.0%，两组比较差异有统计学意义（P＜0.05）；治疗过程中两组均未出现明显不良反应。结论美沙拉嗪联合康复新液治疗溃疡性结肠炎疗效显著，值得临床推广应用。
Objective:Observation of Mesalazine combined with kangfuxin solution treatment of ulcerative colitis (UC) clinical ef icacy and safety. Methods:Choose our hospital 110 cases of patients with ulcerative colitis, al patients were randomly divided into 2 groups,each group 55 cases. Control group given oral Mesalazine treatment, the treatment group in the control group treatment on the basis of combined with kangfuxin solution retention enema, compared two group…查看全部>>
岳洁
四川省宣汉县第三人民医院,四川 宣汉,636150
溃疡性结肠炎美沙拉嗪康复新液疗效
Ulcerative colitisMesalazineKangfuxin solutionEffect
《医学信息》 2013 (16)
184-184,1
评论